" class="no-js "lang="en-US"> Abbisko Archives - Medtech Alert
Tuesday, February 07, 2023

Breaking News

Halozyme Appoints Barbara Duncan to its Board of Directors Dianosic Raises €4.7M to Bring Treatment for Chronic Rhinitis into Clinical Trial Clexio and Genetika+ Announce Partnership Using Proprietary Antidepressant Screening Platform Mihir Patel Joins Cambia Health Solutions as Chief Pharmacy Officer Sandoz Biologics License Application for Proposed Biosimilar Denosumab Accepted by US FDA Chong Kun Dang Pharm and Synaffix Enter a Licensing Agreement Daewoong Pharmaceutical Begins the First Administration of the Bersiporocin, a New Treatment for Idiopathic Pulmonary Fibrosis Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer

Sort by:

Date

Top Post

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience | MTA

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience

Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]

Read more

Industry News

 Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules | Pharmtech Focus

Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules

Abbisko Therapeutics Co., Ltd. (“Abbisko Therapeutics” hereafter), a subsidiary of Abbisko Cayman Limited (Stock Code: […]

  1. Halozyme Appoints Barbara Duncan to its Board of Directors

    Appointments

     Read more
  2. Dianosic Raises €4.7M to Bring Treatment for Chronic Rhinitis into Clinical Trial

    Fundraising

     Read more
  3. Clexio and Genetika+ Announce Partnership Using Proprietary Antidepressant Screening Platform

    News

     Read more
  4. Mihir Patel Joins Cambia Health Solutions as Chief Pharmacy Officer

    Appointments

     Read more
  5. Sandoz Biologics License Application for Proposed Biosimilar Denosumab Accepted by US FDA

    Drug Development

     Read more